Merck
MRK
#39
Rank
$362.26 B
Marketcap
$146.95
Share price
-0.16%
Change (1 day)
60.69%
Change (1 year)

EPS for Merck (MRK)

EPS in 2026 (TTM): $0.99

According to Merck's latest financial reports the company's current EPS (TTM) is $0.99. In 2025 the company made an earnings per share (EPS) of $7.31 an increase over its 2024 EPS that were of $6.76.

EPS history for Merck from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)$0.99-86.42%
2025$7.318.15%
2024$6.764308.46%
2023$0.15-97.32%
2022$5.7310.92%
2021$5.1784.68%
2020$2.80-27.2%
2019$3.8463.44%
2018$2.35151.11%
2017$0.94-54.58%
2016$2.0630.21%
2015$1.58-61.99%
2014$4.16180.51%
2013$1.48-31.82%
2012$2.186.62%
2011$2.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$6.68 572.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$5.25 428.68%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$0.71-28.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$2.70 172.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$30.89 3,010.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$17.38 1,650.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$1.98 99.44%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
$4.52 355.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$2.88 189.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
$0.45-54.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel